Table 2. Total mortality, cardiovascular mortality and major coronary events for men in studies in the ABI Collaboration.
| Total Mortality | Cardiovascular Mortality1 | Major Coronary Events2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Study | Median (Q1,Q3) years of follow-up | Person years of follow-up | Number of deaths | Annual mortality % (95% CI) | Person years of follow-up | Number of deaths | Annual mortality % (95% CI) | Person years of follow-up | Number of events | Annual events % (95% CI) |
| ARIC Study | 13.1 (12.4, 13.9) | 76497 | 903 | 1.18 (1.10 to 1.26) | 76497 | 170 | 0.22 (0.19 to 0.26) | 73991 | 571 | 0.77 (0.71 to 0.83) |
| Belgian Physical Fitness Study | 10.9 (10.5, 11.4) | 22292 | 83 | 0.37 (0.29 to 0.45) | 22292 | 13 | 0.06 (0.03 to 0.09) | 22136 | 98 | 0.44 (0.36 to 0.53) |
| Cardiovascular Health Study | 11.0 (7.2, 11.6) | 16583 | 839 | 5.06 (4.73 to 5.39) | 16583 | 263 | 1.59 (1.40 to 1.78) | 15542 | 432 | 2.78 (2.52 to 3.04) |
| Edinburgh Artery Study | 15.5 (9.0, 15.9) | 8667 | 295 | 3.40 (3.02 to 3.79) | 8667 | 84 | 0.97 (0.76 to 1.18) | 8090 | 113 | 1.40 (1.14 to 1.65) |
| Framingham Offspring Study | 7.4 (6.6, 8.2) | 10182 | 113 | 1.11 (0.91 to 1.31) | 10182 | 20 | 0.20 (0.11 to 0.28) | 10052 | 56 | 0.56 (0.41 to 0.70) |
| Health in Men Study | 6.3 (5.9, 6.5) | 16446 | 402 | 2.44 (2.21 to 2.68) | 16446 | 114 | 0.69 (0.57 to 0.82) | - | - | - |
| Honolulu Heart Program | 6.2 (5.5, 6.9) | 17976 | 882 | 4.91 (4.59 to 5.22) | 17976 | 231 | 1.29 (1.12 to 1.45) | 17703 | 205 | 1.16 (1.00 to 1.32) |
| Hoorn Study | 12.5 (9.8, 13.1) | 2969 | 88 | 2.96 (2.35 to 3.57) | 2969 | 26 | 0.88 (0.54 to 1.21) | - | - | - |
| InCHIANTI Study | 3.0 (2.9, 3.1) | 1427 | 30 | 2.10 (1.36 to 2.85) | 1427 | 11 | 0.77 (0.32 to 1.22) | - | - | - |
| Limburg PAOD Study | 7.1 (6.6, 7.7) | 7088 | 148 | 2.09 (1.76 to 2.42) | 7088 | 34 | 0.48 (0.32 to 0.64) | 6864 | 82 | 1.19 (0.94 to 1.45) |
| Men born in 1914 Study | 13.3 (8.1, 13.9) | 4248 | 182 | 4.28 (3.68 to 4.89) | 4248 | 70 | 1.65 (1.26 to 2.03) | 4028 | 92 | 2.28 (1.82 to 2.75) |
| Rotterdam Study | 10.9 (8.2, 11.8) | 20538 | 813 | 3.96 (3.70 to 4.23) | 20538 | 221 | 1.08 (0.94 to 1.23) | 19805 | 260 | 1.31 (1.15 to 1.47) |
| San Diego Study | 16.7 (10.4, 22.3) | 3843 | 156 | 4.06 (3.44 to 4.68) | 3843 | 77 | 2.00 (1.56 to 2.45) | 3581 | 80 | 2.23 (1.75 to 2.72) |
| San Luis Valley Diabetes Study | 15.6 (14.4, 16.9) | 9765 | 167 | 1.71 (1.45 to 1.97) | 9765 | 51 | 0.52 (0.38 to 0.67) | 9265 | 82 | 0.89 (0.69 to 1.08) |
| Strong Heart Study | 9.7 (8.9, 10.4) | 14935 | 481 | 3.22 (2.94 to 3.50) | 14935 | 122 | 0.82 (0.67 to 0.96) | 14573 | 184 | 1.27 (1.09 to 1.46) |
| TOTAL | 233457 | 5582 | 233457 | 1507 | 205628 | 2255 | ||||
Q1,Q3 = lower and upper quartiles.
1
Cardiovascular mortality is death due to coronary heart disease or stroke.
2
Major coronary events are myocardial infarction or deaths from coronary heart disease. Data not available for 3 studies.